Skip to Main Content

Author Details

Paulo Vidal Campregher
Hospital Israelita Albert Einstein
2007
51
13
PMIDPaper TitleJournal TitlePublished Year
36629680Molecular profile of patients with myelofibrosis: a 10-year experience.Einstein (Sao Paulo)2023
37165281Real-world genomic profiling of acute myeloid leukemia and the impact of European LeukemiaNet risk stratification 2022 update.Clin Transl Oncol2023
35245845EGFR-RAD51 fusion in lung adenocarcinoma with systemic and intracranial response to osimertinib: A case report and review of the literature.Lung Cancer2022
35756679Molecular Characterization of a First-in-Human Clinical Response to Nimesulide in Acute Myeloid Leukemia.Front Oncol2022
36063163Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).Genet Med2022
35101336Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).Genet Med2022
32911384Stereotyped B-cell receptors in the context of a diverse Brazilian series of chronic lymphocytic leukemia.Blood Cells Mol Dis2021
34036626Severe acute respiratory syndrome coronavirus 2 and herpesvirus in oral lesions in patients with severe coronavirus disease 2019: Viral interaction?J Dermatol2021
33170334Multi-center real-world comparison of the fully automated Idyllaâ¿¢ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer.Virchows Arch2021
33423385How I investigate minimal residual disease in acute lymphoblastic leukemia.Int J Lab Hematol2021
33393719High-throughput sequencing of immunoglobulin heavy chain for minimal residual disease detection in B-lymphoblastic leukemia.Int J Lab Hematol2021
31628430Prognostic impact of RAS-pathway mutations in patients with myelofibrosis.Leukemia2020
32535855Genomic characterization and prognostication applied to a Brazilian cohort of patients with myelofibrosis.Int J Hematol2020
31286322Autophagy inhibition potentiates ruxolitinib-induced apoptosis in JAK2<sup>V617F</sup> cells.Invest New Drugs2020
30785480Pre-analytical parameters associated with unsuccessful karyotyping in myeloid neoplasm: a study of 421 samples.Braz J Med Biol Res2019
31373034Distinctive IGHV gene usage and stereotyped receptors in South American patients with chronic lymphocytic leukemia.Hematol Oncol2019
27650062Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm.Br J Haematol2018
30187210Overall survival of Brazilian acute myeloid leukemia patients according to the European LeukemiaNet prognostic scoring system: a cross-sectional study.Med Oncol2018
30370409ZAP-70 expression is associated with increased CD4 central memory T cells in chronic lymphocytic leukemia: cross-sectional study.Hematol Transfus Cell Ther2018
27903463HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib.J Thorac Oncol2017
28509585Identification of a novel fusion TBL1XR1-PDGFRB in a patient with acute myeloid leukemia harboring the DEK-NUP214 fusion and clinical response to dasatinib.Leuk Lymphoma2017
28746593Ferritin light chain gene mutations in two Brazilian families with hereditary hyperferritinemia-cataract syndrome.Einstein (Sao Paulo)2017
28746590Successful treatment of post-transplant relapsed acute myeloid leukemia with FLT3 internal tandem duplication using the combination of induction chemotherapy, donor lymphocyte infusion, sorafenib and azacitidine. Report of three cases.Einstein (Sao Paulo)2017
28737776Therapeutic salivary monitoring of IV busulfan in patients undergoing hematopoietic stem cell transplantation: a pilot study.Bone Marrow Transplant2017
26994960Clinical features of JAK2V617F- or CALR-mutated essential thrombocythemia and primary myelofibrosis.Blood Cells Mol Dis2016
28074183A Novel Assay for the Identification of NOTCH1 PEST Domain Mutations in Chronic Lymphocytic Leukemia.Biomed Res Int2016
27176796Clinical response to everolimus in a patient with Hodgkin's lymphoma harboring a TSC2 mutation.Blood Cancer J2016
26958979Immunophenotypic evolution of blast populations in pediatric acute myeloid leukemia.Einstein (Sao Paulo)2016
27036161A novel mechanism of NPM1 cytoplasmic localization in acute myeloid leukemia: the recurrent gene fusion NPM1-HAUS1.Haematologica2016
25645430Survival and graft-versus-host disease in patients receiving peripheral stem cell compared to bone marrow transplantation from HLA-matched related donor: retrospective analysis of 334 consecutive patients.Eur J Haematol2015
26361371The role of magnetic resonance imaging-T2* in the evaluation of iron overload early in hereditary hemochromatosis. A cross-sectional study with 159 patients.Am J Hematol2015
26584717Identification of ANLN as ETV6 partner gene in recurrent t(7;12)(p15;p13): a possible role of deregulated ANLN expression in leukemogenesis.Mol Cancer2015
26667746HIGH BODY MASS INDEX AMONG PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION: RESULTS OF A CROSS-SECTIONAL EVALUATION OF NUTRITIONAL STATUS IN A PRIVATE HOSPITAL.Nutr Hosp2015
26193901Eosinophil chimerism in the differential diagnosis between DEK-NUP214-positive acute myeloid leukaemia relapse and chronic graft-versus-host disease.J Clin Pathol2015
25658984Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy.Blood Cancer J2015
24266414Metastatic melanoma mimicking acute leukaemia.Br J Haematol2014
25305159Does angiogenesis matter in primary myelofibrosis?Rev Bras Hematol Hemoter2014
25030673[Not Available].Rev Bras Hematol Hemoter2014
24548608Novel prognostic gene mutations identified in chronic lymphocytic leukemia and their impact on clinical practice.Clin Lymphoma Myeloma Leuk2014
24624038Involvement of memory T-cells in the pathophysiology of chronic lymphocytic leukemia.Rev Bras Hematol Hemoter2014
23588288Primary central nervous system lymphoma: what a neurologist/neurosurgeon should know?Arq Neuropsiquiatr2013
24168776Development of plasma cell myeloma in a B-cell chronic lymphocytic leukemia patient with chromosome 12 trisomy.BMC Res Notes2013
23049405Molecular biology of Philadelphia-negative myeloproliferative neoplasms.Rev Bras Hematol Hemoter2012
23386005The detection of KIT mutations in acute myeloid leukemia.Einstein (Sao Paulo)2012
20053332Lung function and long-term complications after allogeneic hematopoietic cell transplant.Biol Blood Marrow Transplant2010
20811043Overlap and effective size of the human CD8+ T cell receptor repertoire.Sci Transl Med2010
20035823Abnormalities of the alphabeta T-cell receptor repertoire in advanced myelodysplastic syndrome.Exp Hematol2010
19470693Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.Blood2009
19706884Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells.Blood2009
19041060Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.Biol Blood Marrow Transplant2008
  • 1 - 50 of 51

Recommended Authors

Huntsman Cancer Institute at the University of Utah.
Career Start Year 2012
Number of shared co-authors 1
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 2
Universite de Paris, Inserm CIC 1427
Career Start Year 2009
Number of shared co-authors 0
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 3
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 0
Hannover Medical School
Career Start Year 2007
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 1
Universite Nice Cote d'azur, CHU de Nice
Career Start Year 2005
Number of shared co-authors 2
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 4
Hannover Medical School
Career Start Year 2002
Number of shared co-authors 0
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 1
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 5
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 1
Tuen Mun Hospital
Career Start Year 1999
Number of shared co-authors 0
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 8
University Hospital Erlangen
Career Start Year 1998
Number of shared co-authors 0
AbbVie Inc.
Career Start Year 1996
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 1
Hospital Weissenfels
Career Start Year 1994
Number of shared co-authors 1
Kyoto University
Career Start Year 1993
Number of shared co-authors 1
University of Paris
Career Start Year 1993
Number of shared co-authors 1
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 2
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 4
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 1
Fred Hutchinson Cancer Center
Career Start Year 1989
Number of shared co-authors 5
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Career Start Year 1989
Number of shared co-authors 1
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 1983
Number of shared co-authors 2
Sapienza University.
Career Start Year 1968
Number of shared co-authors 1

Collaborators

Foundation Medicine
Co-authored papers 4
Foundation Medicine
Co-authored papers 4
Injury Prevention Research Center, University of North Carolina
Co-authored papers 4
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 2
Centene Center for Health Transformation, Centene Corporation
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
Mayo Clinic Foundation
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
University of Washington
Co-authored papers 2
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 2
Innovation Center for Biomedical Informatics, Georgetown University Medical Center
Co-authored papers 2
National Cancer Center Hospital
Co-authored papers 2
Association for Molecular Pathology
Co-authored papers 2
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 2
Washington University School of Medicine
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
University of Cincinnati College of Medicine
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
Universitat Pompeu Fabra
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
Washington University
Co-authored papers 2
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 2
Genomic Medicine Institute, Cleveland Clinic Lerner Research Institute
Co-authored papers 2
Washington University
Co-authored papers 2
German Cancer Consortium and German Cancer Research Center
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Indiana University School of Medicine
Co-authored papers 2